MedTrace Logo

Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment

NCT01364818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-04-18

No results posted yet for this study

Summary

The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain psychophysical measurements throughout several periods of treatment.

Conditions

  • Autism Spectrum Disorders
  • Psychosis
  • Fragile X Syndrome

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Linmarie Sikich, M.D. · University of North Carolina, Chapel Hill

Eligibility

Min Age
3 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01364818 on ClinicalTrials.gov